iomeprol has been researched along with Neoplasms in 9 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"27% patients had colon cancer, 18% lung cancer." | 1.42 | Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions. ( Colombo, B; Cornalba, G; Flor, N; Lombardi, MA; Luciani, A; Tresoldi, S, 2015) |
"Increased age is linked with a higher cancer risk according to model calculations." | 1.40 | Incidental findings in computed tomographic angiography for planning percutaneous aortic valve replacement: advanced age, increased cancer prevalence? ( Gufler, H; Schulze, CG; Wagner, S, 2014) |
"The influences of malignancy, elevated central venous pressure and age on the development of a CC proved to be highly significant but could not be separated or quantified." | 1.37 | Cisterna chyli in patients with malignancy--influence of cardiovascular disease on the prevalence of the cisterna. ( Brambs, HJ; Feuerlein, S; Hetzel, M; Klass, O; Muche, R; Pauls, S; Stolz, J, 2011) |
"Venous thrombosis is a common occurrence in cancer patients, developing spontaneously or in combination with indwelling central venous devices (CVD)." | 1.37 | Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings. ( Aprea, P; Catalano, O; D'Errico, AG; de Lutio di Castelguidone, E; Granata, V; Petrillo, M; Sandomenico, C, 2011) |
"VCT shows the vessel architecture of tumors and animals with greater detail and plasticity than has previously been achieved, and is superior to contrast-enhanced magnetic resonance (MR) angiography." | 1.32 | Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. ( Bock, M; Fink, C; Fusenig, NE; Greschus, S; Kiessling, F; Lichy, MP; Moll, J; Mueller, MM; Semmler, W; Traupe, H; Vosseler, S, 2004) |
"Iomeprol 400 was the strongest inhibitor and Gadopenteic acid the weakest inhibitor for each IRMA of the contrast agents employed." | 1.30 | In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens. ( Endo, K; Fukushima, Y; Higuchi, T; Hirano, T; Inoue, T; Oriuchi, N; Tomiyoshi, K; Watanabe, N; Yukihiro, M, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagayama, Y | 1 |
Nakaura, T | 1 |
Oda, S | 1 |
Tsuji, A | 1 |
Urata, J | 1 |
Furusawa, M | 1 |
Tanoue, S | 1 |
Utsunomiya, D | 1 |
Yamashita, Y | 1 |
Gufler, H | 1 |
Schulze, CG | 1 |
Wagner, S | 1 |
Tresoldi, S | 1 |
Flor, N | 1 |
Luciani, A | 1 |
Lombardi, MA | 1 |
Colombo, B | 1 |
Cornalba, G | 1 |
Tamura, M | 1 |
Ito, H | 1 |
Matsui, H | 1 |
Heusner, TA | 1 |
Kuehl, H | 1 |
Veit-Haibach, P | 1 |
Hahn, S | 1 |
Boy, C | 1 |
Forsting, M | 1 |
Bockisch, A | 1 |
Antoch, G | 1 |
Feuerlein, S | 1 |
Stolz, J | 1 |
Muche, R | 1 |
Hetzel, M | 1 |
Klass, O | 1 |
Brambs, HJ | 1 |
Pauls, S | 1 |
Catalano, O | 1 |
de Lutio di Castelguidone, E | 1 |
Sandomenico, C | 1 |
Petrillo, M | 1 |
Aprea, P | 1 |
Granata, V | 1 |
D'Errico, AG | 1 |
Kiessling, F | 1 |
Greschus, S | 1 |
Lichy, MP | 1 |
Bock, M | 1 |
Fink, C | 1 |
Vosseler, S | 1 |
Moll, J | 1 |
Mueller, MM | 1 |
Fusenig, NE | 1 |
Traupe, H | 1 |
Semmler, W | 1 |
Watanabe, N | 1 |
Oriuchi, N | 1 |
Higuchi, T | 1 |
Yukihiro, M | 1 |
Fukushima, Y | 1 |
Tomiyoshi, K | 1 |
Hirano, T | 1 |
Inoue, T | 1 |
Endo, K | 1 |
9 other studies available for iomeprol and Neoplasms
Article | Year |
---|---|
Value of 100 kVp scan with sinogram-affirmed iterative reconstruction algorithm on a single-source CT system during whole-body CT for radiation and contrast medium dose reduction: an intra-individual feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Feasibility Studies; Female; Humans; Ima | 2018 |
Incidental findings in computed tomographic angiography for planning percutaneous aortic valve replacement: advanced age, increased cancer prevalence?
Topics: Age Factors; Aged; Aged, 80 and over; Aortic Valve Stenosis; Blood Vessel Prosthesis Implantation; C | 2014 |
Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Contrast Media; False Negative Reactions; False P | 2015 |
Radiotherapy for cancer using X-ray fluorescence emitted from iodine.
Topics: Animals; Cell Line, Tumor; Cell Survival; Contrast Media; Disease Models, Animal; Fluorescence; Iodi | 2017 |
Highly iodinated intravenous contrast material for PET/CT - a feasibility study.
Topics: Adolescent; Adult; Aged; Artifacts; Dose-Response Relationship, Drug; Feasibility Studies; Female; H | 2008 |
Cisterna chyli in patients with malignancy--influence of cardiovascular disease on the prevalence of the cisterna.
Topics: Aged; Azygos Vein; Cardiovascular Diseases; Contrast Media; Female; Humans; Iopamidol; Logistic Mode | 2011 |
Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catheterization, Central Venous; Contrast Media; Female; | 2011 |
Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis.
Topics: Animals; Barium Sulfate; Histological Techniques; Iohexol; Iopamidol; Magnetic Resonance Imaging; Mi | 2004 |
In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, T | 1998 |